Stay ahead with
clearer skin and less itch

DUPIXENT in combination with a topical corticosteroid was studied in a 16-week clinical trial in 367 patients ages 6-11 years with severe eczema not adequately controlled with topical prescription treatments.

 

DUPIXENT results
in children

From a clinical trial at 16 weeks (DUPIXENT* + topical corticosteroids [TCS] vs TCS only):

~2X
SAW CLEAR OR
ALMOST CLEAR SKIN

30% 300 mg DUPIXENT every 4 weeks
+ TCS vs 13% TCS only

39% 200 mg DUPIXENT every 2 weeks
+ TCS vs 10% TCS only

~4.5X
HAD noticeably
LESS ITCH

54% 300 mg DUPIXENT every 4 weeks
+ TCS vs 12% TCS only

61% 200 mg DUPIXENT every 2 weeks
+ TCS vs 13% TCS only

≥75%
Clearer skin in
more
than half of
children

75% 300 mg DUPIXENT every 4 weeks + TCS
vs 28% TCS only

75% 200 mg DUPIXENT every 2 weeks + TCS vs
26% TCS only

Your healthcare provider will tell you how much DUPIXENT to inject and how often.

*After an initial loading dose of 2 injections, children less than 66 lb received 300 mg every 4 weeks; children 66 lb or more received 200 mg every 2 weeks.

 

View BEFORE AND AFTER
PHOTOS IN CHILDREN

Click and drag
to see results
Click and drag
to see results

Before and after results of an actual 10-year-old patient and 9-year-old patient after 16 weeks of treatment with DUPIXENT and a topical steroid in a phase 3 clinical trial. These patients met clinical trial criteria for clear or almost clear skin. Individual results may vary.

LONG-TERM SAFETY
RESULTS IN CHILDREN

Long-term safety results for children continuing on DUPIXENT with or without TCS in the pediatric extension study through 1 year were consistent with the adult clinical trials.

MOST COMMON SIDE
EFFECTS INCLUDE:

  • Injection site reactions
  • Eye and eyelid inflammation, including redness, swelling, and itching, sometimes with blurred vision
  • Dry eye
  • Cold sores in your mouth or on your lips
  • High count of a certain white blood cell (eosinophilia)

View the possible side effects of DUPIXENT


What You Should Know About the Patients in this Study:

100%
Had severe
atopic dermatitis
~8.5 years
Average age
~58%
Average body surface
area involvement

Have you spoken to a dermatologist or allergist about DUPIXENT?

Great! Sign up for DUPIXENT MyWay®, our patient support program, to access program benefits and get one-on-one support every step of the way, including help with filling your first prescription.

Finding the right eczema treatment starts with the right kind of conversation.

Answer a few short questions about your eczema symptoms and treatment goals. We’ll turn it into a personalized guide you can use at your next visit.

Working with a dermatologist or allergist can lead to a more accurate diagnosis and more impactful treatment for your eczema.

I’m really proud of Catch taking his
DUPIXENT injection. At first, he
resisted, but now he sees the benefits
of taking DUPIXENT.

Amber,

DUPIXENT MyWay® Caregiver and Patient
Ambassador. Individual results may vary.

WATCH MORE
CAREGIVER STORIES